{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for azelaic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
NCT00003478: Phase 1/Phase 2 Interventional Completed Brain and Central Nervous System Tumors
(1997)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02119819: Phase 2 Interventional Completed Diabetes Mellitus, Type 2
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01222286: Phase 2 Interventional Completed Smoldering Multiple Myeloma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03708224: Phase 2 Interventional Recruiting Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04130854: Phase 2 Interventional Active, not recruiting Locally Advanced Rectal Adenocarcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01439971: Phase 1 Interventional Completed Hemophilia A
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:vadastuximab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00568594: Phase 1/Phase 2 Interventional Completed Coronary Heart Disease
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:paridiprubart [INN]
Source URL:
Class:
PROTEIN
